Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Closing 140 plus today???? Definitely a possibility!!!! Go AAPL!
Totally agree with you my friend. Affordable price with a history of continual growth. No brainer for anyone who holds for the long haul! Ad new 5g phones being sold around the corner.... next quarter should be interesting. GLTA except Shorty!
Loving the positive vibes on AAPL board. Definitely on an upward trend $$$$$$$
Apple (AAPL) shares touched new intraday highs on Tuesday, continuing Monday’s rally amid the stock’s 4-for-1 split.
Year-to-date Apple is up 80%, while the S&P 500 (^GSPC) is up about 8%. The move has some analysts on their heels as they aim to explain what’s happening to their clients.
In a research note to clients, BofA analyst Wamsi Mohan highlighted possible factors behind the stock’s “unprecedented strong run of outperformance vs. the broader market.”
A recent “inflow of retail investors” suggests momentum as a factor, he said.
“Our conversations with institutional investors suggest that Fear Of Missing Out (FOMO) is not yet at work given the relatively quick rerating and concern that fundamentals can't support continued upside,” he wrote.
“Some investors cite that within the hardware universe, There Is No Alternative (TINA) to AAPL's cash flows and could be driving part of the price action although clearly there are other mega caps with strong cash flows as well (but different risk profiles),” wrote Mohan.
With the note, the analyst raised his price target on the iPhone maker to $140 while maintaining a Neutral rating.
“Analyzing the past few weeks of trading data suggests a strong inflow from retail investors, suggesting MOMO (momentum) is the strongest attributable factor,” he said, while warning that “momentum can cut both ways, especially given risk to Sep/Dec qtr estimates (particularly on high end iPhones).”
Though he noted that “in the short term momentum can trump valuation."
A view of an Apple Store at The Oculus as New York City continues Phase 4 of re-opening following restrictions imposed to slow the spread of coronavirus on August 13, 2020 in New York City.
A view of an Apple Store at The Oculus as New York City continues Phase 4 of re-opening following restrictions imposed to slow the spread of coronavirus on August 13, 2020 in New York City.
Apple is expected release its next generation 5G iPhone this fall.
Following the tech giant’s latest quarterly results in July, WedBush’s Dan Ives told Yahoo Finance the “massive home-run type quarter” is a drumroll for what’s to come with the new iPhones. He specified that 350 million of 950 million global iPhone users have not upgraded their phones in three and a half years.
Apple has reportedly asked suppliers to make 75 million 5G iPhone units for later this year, along with the launch of a new iPad air and new watches.
Share of Apple were trading at around $134 in afternoon trading, up 3.9% on the day.
Great read!!!!!
Go GILD$$$$$
Following u, appreciate a follow back
Good luck my friend
Great, u reposting my post.... thumbs down emoji
I’ll take that my friend.... after phase 3 is completed we shall have a better understanding where mRNA stands. Again, best of trades to you $$$$$$$$$
Know what you own folks. GLTA except shorty. Been here since 40 and not selling!!!!!! 20 percent of this stock is shorted.... positive news and mRNA flies sky high again$$$$$$$
Need to educate yourself. It’s All coming together. Good luck. Phase 3 almost complete. FDA gives the approval,,Who knows how high.
Any news or updates?
https://www.foxnews.com/politics/historic-vote-marijuana-decriminalization
Game changer if bill passes!
The Food and Drug Administration late Friday expanded its emergency use authorization for Gilead Sciences’ Covid-19 therapeutic remdesivir, saying the drug can now be used in any patient hospitalized for Covid-19.
The agency previously had authorized the unapproved treatment for only the sickest Covid-19 patients. The FDA said it now believes that the drug “may be effective” in all hospitalized Covid-19 patients, and that the potential benefits outweigh the known and potential risks.
$$$$$$$$$$$$$$$$$
https://finance.yahoo.com/m/9f7d275e-7944-38af-a4cc-6003276ffefd/moderna-in-talks-with-japan.html
Looking good here $$$$$$$$$